Epilepsy and hippocampal neurodegeneration induced by glutamate decarboxylase inhibitors in awake rats

Epilepsy Research

Volumn 116, Issue , 2015, Pages 27-33

  Salazar, Patricia ^a   Tapia, Ricardo ^a  

^a INSTITUTO DE FISIOLOGÍA CELULAR   (Mexico)

Author keywords

Epilepsy; GABA; Glutamate; Hippocampus; Neurodegeneration; Pyridoxal phosphate

Indexed keywords

3 MERCAPTOPROPIONIC ACID; 4 AMINOBUTYRIC ACID; ASPARTIC ACID; DIZOCILPINE; ENZYME INHIBITOR; GAMMA GLUTAMYL HYDRAZONE; GLUTAMATE DECARBOXYLASE; GLUTAMIC ACID; THIOSEMICARBAZIDE; UNCLASSIFIED DRUG; ALPHA-METHOXY-ALPHA-PHENYLACETIC ACID; AMINO ACID; DIZOCILPINE MALEATE; NEUROPROTECTIVE AGENT; PHENYLACETIC ACID DERIVATIVE; PYRIDOXAL 5 PHOSPHATE; PYRIDOXAL PHOSPHATE GAMMA-GLUTAMYL HYDRAZONE; SEMICARBAZIDE DERIVATIVE;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN DEPTH STIMULATION; CONTROLLED STUDY; ELECTROENCEPHALOGRAM; EPILEPSY; EXTRACELLULAR SPACE; HIPPOCAMPAL CA1 REGION; LOCOMOTION; NERVE DEGENERATION; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; RAT; WAKEFULNESS; ANALOGS AND DERIVATIVES; ANIMAL; CHEMICALLY INDUCED; DISEASE MODEL; DOSE RESPONSE; HIPPOCAMPUS; MALE; METABOLISM; MICRODIALYSIS; NEURODEGENERATIVE DISEASES; PATHOLOGY; TIME FACTOR; WISTAR RAT;

AMINO ACIDS; ANIMALS; DISEASE MODELS, ANIMAL; DIZOCILPINE MALEATE; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; EPILEPSY; HIPPOCAMPUS; MALE; MICRODIALYSIS; NEURODEGENERATIVE DISEASES; NEUROPROTECTIVE AGENTS; PHENYLACETATES; PYRIDOXAL PHOSPHATE; RATS; RATS, WISTAR; SEMICARBAZIDES; TIME FACTORS; WAKEFULNESS;

EID: 84940503137     PISSN: 09201211     EISSN: 18726844     Source Type: Journal    
DOI: 10.1016/j.eplepsyres.2015.06.014     Document Type: Article

References (49)

1. Abe M., Matsuda M. Effect of antivitamin B6 on regional GABA metabolism in mouse brain and its relation to convulsions. J. Nutr. Sci. Vitaminol. 1979, 25:459-468.
2. Antonucci F., Alpár A., Kacza J., Caleo M., Verderio C., Giani A., Martens H., Chaudhry F.A., Allegra M., Grosche J., Michalski D., Erck C., Hoffmann A., Harkany T., Matteoli M., Härtig W. Cracking down on inhibition: selective removal of GABAergic interneurons from hippocampal networks. J. Neurosci. 2012, 32:1989-2001.
3. Asada H., Kawamura Y., Maruyama K., Kume H., Ding R., Ji F.Y., Kanbara N., Kuzume H., Sanbo M., Yagi T., Obata K. Mice lacking the 65kDa isoform of glutamic acid decarboxylase (GAD65) maintain normal levels of GAD67 and GABA in their brains but are susceptible to seizures. Biochem. Biophys. Res. Commun. 1996, 229:891-895.
4. Asada H., Kawamura Y., Maruyama K., Kume H., Ding R.G., Kanbara N., Kuzume H., Sanbo M., Yagi T., Obata K. Cleft palate and decreased brain gamma-aminobutyric acid in mice lacking the 67-kDa isoform of glutamic acid decarboxylase. Proc. Natl. Acad. Sci. U.S.A. 1997, 94:6496-6499.
5. Ayala G.X., Tapia R. Late N-methyl-d-aspartate receptor blockade rescues hippocampal neurons from excitotoxic stress and death after 4-aminopyridine-induced epilepsy. Eur. J. Neurosci. 2005, 22:3067-3076.
6. Battaglioli G., Liu H., Martin D.L. Kinetic differences between the isoforms of glutamate decarboxylase: implications for the regulation of GABA synthesis. J. Neurochem. 2003, 86:879-887.
7. Bayón A., Possani L.D., Tapia M., Tapia R. Kinetics of brain glutamate decarboxylase. Interactions with glutamate, pyridoxal 5'-phosphate and glutamate-pyridoxal 5'-phosphate Schiff base. J. Neurochem. 1977, 29:519-525.
8. Bayón A., Possani L.D., Tapia R. Kinetics of brain glutamate decarboxylase. Inhibition studies with N-(5'-phosphopyridoxyl) amino acids. J. Neurochem. 1977, 29:513-517.
9. 6 and brain function in animals and man. Ann. N.Y. Acad. Sci. 1969, 166:7-15.
10. Dunlop C.W., Adey W.R., Killam K.F., Brazier M.A. Mechanism of action of thiosemicarbazide and metrazol on cerebellar and cerebral activity in the cat. Am. J. Physiol. 1960, 198:399-404.
11. Erlander M.G., Tillakaratne N.J., Feldblum S., Patel N., Tobin A.J. Two genes encode distinct glutamate decarboxylases. Neuron 1991, 7:91-100.
12. Esclapez M., Tillakaratne N.J., Kaufman D.L., Tobin A.J., Houser C.R. Comparative localization of two forms of glutamic acid decarboxylase and their mRNAs in rat brain supports the concept of functional differences between the forms. J. Neurosci. 1994, 14:1834-1855.
13. Fan S.G., Zhou J.P., Xu H., Han J.S. The effect of intracerebroventricular 3-mercaptopropionic acid on blood pressure and heart rate in the rat. Brain Res. 1985, 337:184-187.
14. Goyal M., Fequiere P.R., McGrath T.M., Hyland K. Seizures with decreased levels of pyridoxal phosphate in cerebrospinal fluid. Pediatr. Neurol. 2013, 48:227-231.
15. Horton R.W., Meldrum B.S. GABA and seizures induced by inhibitors of glutamic acid decarboxylase. Brain Res. Bull. 1973, 49:52-63.
16. Houser C.R., Esclapez M. Localization of mRNAs encoding two forms of glutamic acid decarboxylase in the rat hippocampal formation. Hippocampus 1994, 4:530-545.
17. Karlsson A., Fonnum F., Malthe-Sørenssen D., Storm-Mathisen J. Effect of the convulsive agent 3-mercaptopropionic acid on the levels of GABA, other amino acids and glutamate decarboxylase in different regions of the rat brain. Biochem. Pharmacol. 1974, 23:3053-3061.
18. Kash S.F., Johnson R.S., Tecott L.H., Noebels J.L., Mayfield R.D., Hanahan D., Baekkeskov S. Epilepsy in mice deficient in the 65-kDa isoform of glutamic acid decarboxylase. Proc. Natl. Acad. Sci. U.S.A. 1997, 94:14060-14065.
19. Kaufman D.L., Houser C.R., Tobin A.J. Two forms of the gamma-aminobutyric acid synthetic enzyme glutamate decarboxylase have distinct intraneuronal distributions and cofactor interactions. J. Neurochem. 1991, 56:720-723.
20. 6 enzymes by convulsant hydrazides. J. Pharm. Exp. Ther. 1957, 119:255-262.
21. Lamar C. Mercaptopropionic acid: a convulsant that inhibits glutamate decarboxylase. J. Neurochem. 1970, 17:165-170.
22. Löscher W. 3-Mercaptopropionic acid: convulsant properties, effects on enzymes of the gamma-aminobutyrate system in mouse brain and antagonism by certain anticonvulsant drugs, aminooxyacetic acid and gabaculine. Biochem. Pharmacol. 1979, 28:1397-1407.
23. Martin D.L., Martin S.B., Wu S.J., Espina N. Regulatory properties of brain glutamate decarboxylase (GAD): the apoenzyme of GAD is present principally as the smaller of two molecular forms of GAD in brain. J. Neurosci. 1991, 11:2725-2731.
24. Martin J.L., Sloviter R.S. Focal inhibitory interneuron loss and principal cell hyperexcitability in the rat hippocampus after microinjection of a neurotoxic conjugate of saporin and a peptidase-resistant analog of Substance P. J. Comp. Neurol. 2001, 436:127-152.
25. Massieu L., Rivera A., Tapia R. Convulsions and inhibition of glutamate decarboxylase by pyridoxal phosphate-γ-glutamyl hydrazone in the developing rat. Neurochem. Res. 1994, 19:183-187.
26. Netopilova M., Drsata J., Kubova H., Mares P. Differences between immature and adult rats in brain glutamate decarboxylase inhibition by 3-mercaptopropionic acid. Epilepsy Res. 1997, 20:179-184.
27. Obata K., Hirono M., Kume N., Kawaguchi Y., Itohara S., Yanagawa Y. GABA and synaptic inhibition of mouse cerebellum lacking glutamate decarboxylase 67. Biochem. Biophys. Res. Commun. 2008, 370:429-433.
28. O'Connell B.K., Towfighi J., Kofke W.A., Hawkins R.A. Neuronal lesions in mercaptopropionic acid-induced status epilepticus. Acta Neuropathol. 1988, 77:47-54.
29. Patel A.B., de Graaf R.A., Martin D.L., Battaglioli G., Behar K.L. Evidence that GAD65 mediates increased GABA synthesis during intense neuronal activity in vivo. J. Neurochem. 2006, 97:385-396.
30. Paxinos G., Watson C. The Rat Brain in Stereotaxic Coordinates 1982, Academic Press, Sidney.
31. Peña F., Tapia R. Seizures and neurodegeneration induced by 4-aminopyridine in rat hippocampus in vivo: role of glutamate- and GABA-mediated neurotransmission and of ion channels. Neuroscience 2000, 101:547-561.
32. Pérez de la Mora M., Feria-Velasco A., Tapia R. Pyridoxal phosphate and glutamate decarboxylase in subcellular particles of mouse brain and their relationship to convulsions. J. Neurochem. 1973, 20:1575-1587.
33. Rodríguez de Lores Arnaiz G.R., Alberici de Canal M., Robiolo B., Mistrorigo, Pacheco M. The effect of the convulsant 3-mercaptopropionic acid on enzymes of the gamma-aminobutyrate system in the rat cerebral cortex. J. Neurochem. 1973, 21:615-623.
34. Sharma S.K., Dakshinamurti K. Seizure activity in pyridoxine-deficient adult rats. Epilepsia 1992, 33:235-347.
35. Stone D.J., Walsh J., Benes F.M. Localization of cells preferentially expressing GAD(67) with negligible GAD(65) transcripts in the rat hippocampus. A double in situ hybridization study. Brain Res. Mol. Brain Res. 1999, 71:201-209.
36. Tapia R., Awapara J. Formation of gamma-aminobutyric acid (GABA) in brain of mice treated with l-glutamic acid-gamma-hydrazide and pyridoxal phosphate-gamma-glutamyl hydrazone. Proc. Soc. Exp. Biol. Med. 1967, 126:218-221.
37. Tapia R., Awapara J. Effects of various substituted hydrazones and hydrazines of pyridoxal-5'-phosphate on brain glutamate decarboxylase. Biochem. Pharmacol. 1969, 18:145-152.
38. Tapia R., Pérez de la Mora M., Massieu G.H. Correlative changes of pyridoxal kinase pyridoxal-5'-phosphate and glutamate decarboxylase in brain, during drug-induced convulsions. Ann. N.Y. Acad. Sci. 1969, 166:257-266.
39. 6-dependent enzymes and convulsions. Brain Res. 1971, 29:111-122.
40. Tapia R. Biochemical pharmacology of GABA in CNS. Handbook of Psychopharmacology 1975, vol. 4:1-58. Plenum Press, New York.
41. Tapia R., Sandoval M.E., Contreras P. Evidence for a role of glutamate decarboxylase activity as a regulatory mechanism of cerebral excitability. J. Neurochem. 1975, 24:1283-1285.
42. Tapia R. γ-Aminobutyric acid: metabolism, and biochemistry of synaptic transmission. Handbook of Neurochemistry 1983, vol. 3:423-466. Plenum Press, New York. 2nd ed.
43. Tapia R., Salazar P. Glutamate decarboxylase activity in the substantia nigra and the hippocampus of rats microinjected with inhibitors of the enzyme. Neurochem. Res. 1991, 16:263-267.
44. Tian N., Petersen C., Kash S., Baekkeskov S., Copenhagen D., Nicoll R. The role of the synthetic enzyme GAD65 in the control of neuronal gamma-aminobutyric acid release. Proc. Natl. Acad. Sci. U.S.A. 1999, 96:12911-12916.
45. Towfighi J., Kofke W.A., O'Connell B.K., Housman C., Graybeal J.M. Substantia nigra lesions in mercaptopropionic acid induced status epilepticus: a light and electron microscopic study. Acta Neuropathol. 1989, 77:612-620.
46. Vera G., Tapia R. Activation of group III metabotropic glutamate receptors by endogenous glutamate protects against glutamate-mediated excitotoxicity in the hippocampus in vivo. J. Neurosci. Res. 2012, 90:1055-1066.
47. Veerapandiyan A., Wincheste S.A., Gallentine W.B., Smith E.C., Sujay Kansagra S., Keith Hyland K., Mikati M.A. Electroencephalographic and seizure manifestations of pyridoxal 5'-phosphate-dependent epilepsy. Epilepsy Behav. 2011, 20:494-501.
48. Walls A.B., Eyjolfsson E.M., Smeland O.B., Nilsen L.H., Schousboe I., Schousboe A., Sonnewald U., Waagepetersen H.S. Knockout of GAD65 has major impact on synaptic GABA synthesized from astrocyte-derived glutamine. J. Cereb. Blood Flow Metab. 2011, 31:494-503.
49. Wu J.Y., Roberts E. Properties of brain l-glutamate decarboxylase: inhibition studies. J. Neurochem. 1974, 23:759-767.